Abstract
Vitamin D has various systemic effects on bone metabolism, modulation of the immune system, stabilization of the cell membrane, oxidative stress, inflammation, apoptosis, and various other hormones. Differing from active vitamin D, paricalcitol is a relatively safe VDR agonist due to its relatively few side effects. This study has investigated the anticonvulsant effect of paricalcitol in convulsions induced by pentylenetetrazole (PTZ). 36 male Sprague-Dawley rats were divided randomly into two groups: 18 for EEG recording (PTZ 35 mg/kg) and 18 for behavioral studies (PTZ 70 mg/kg). Forty-five minutes before the PTZ injection, both groups of rats were given 5 and 10 μg/kg of paricalcitol i.p., respectively. Racine convulsion scores, first myoclonic jerk time, spike percentages, and antioxidant status were evaluated in the groups. Our results showed that the Racine’s Convulsion Scale (RCS) score significantly dropped in the paricalcitol-treated group, analysis of the first myoclonic jerk (FMJ) latencies demonstrated a significantly longer latency in the paricalcitol-applied group, and spike percentages at EEG recordings significantly decreased with paricalcitol. Moreover, MDA levels were lower and SOD activity were higher in the 5 μg/kg paricalcitol group compared to the saline group; these results were more prominent in 10 μg/kg paricalcitol group. Our study has demonstrated that paricalcitol has protective effects on PTZ-induced convulsions. Based on the SOD and MDA levels in our study, these effects may result from the antioxidant characteristics of paricalcitol.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abraham J, Fox PD, Condello C, Bartolini A, Koh S (2012) Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures. Neurobiol Dis 46:425–430. doi:10.1016/j.nbd.2012.02.006
Adams JS, Hewison M (2010) Update in vitamin D. J Clin Endocrinol Metab 95:471–478. doi:10.1210/jc.2009-1773
Adams RDVM (1989) Principles of neurology, 4th edn. McGraw-Hill, New York, pp. 249–258
Aeby A, Poznanski N, Verheulpen D, Wetzburger C, Van Bogaert P (2005) Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases. Epilepsia 46:1937–1942. doi:10.1111/j.1528-1167.2005.00337.x
Al-Temaimi RA, Al-Enezi A, Al-Serri A, Alroughani R, Al-Mulla F (2015) The association of vitamin D receptor polymorphisms with multiple sclerosis in a case-control study from Kuwait. PLoS One 10:e0142265. doi:10.1371/journal.pone.0142265
Andress D (2007) Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease. Drugs 67:1999–2012
Balint E, Marshall CF, Sprague SM (2000) Effect of the vitamin D analogues paricalcitol and calcitriol on bone mineral in vitro. Am J Kidney Dis: Off J Natl Kidney Found 36:789–796. doi:10.1053/ajkd.2000.17667
Bikle D (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94:26–34. doi:10.1210/jc.2008-1454
Borowicz KK, Morawska D, Morawska M (2015) Effect of cholecalciferol on the anticonvulsant action of some second generation antiepileptic drugs in the mouse model of maximal electroshock. Pharmacol Rep 67:875–880. doi:10.1016/j.pharep.2015.01.012
Carswell S (1997) Vitamin D in the nervous system: actions and therapeutic potential. In: Feldman D, Glorieux FH, Pike JW (eds) Vitamin D. San-Diego: Academic Press, pp. 1197–1211
Demougeot C, Marie C, Beley A (2000) Importance of iron location in iron-induced hydroxyl radical production by brain slices. Life Sci 67:399–410
Erbas O, Solmaz V, Aksoy D (2015) Inhibitor effect of dexketoprofen in rat model of pentylenetetrazol-induced seizures. Neurol Res 37:1096–1101. doi:10.1179/1743132814Y.0000000391
Erbas O, Yilmaz M, Korkmaz HA, Bora S, Evren V, Peker G (2013) Oxytocin inhibits pentylentetrazol-induced seizures in the rat. Peptides 40:141–144. doi:10.1016/j.peptides.2012.12.003
Holick MF (2010) Vitamin D: extraskeletal health. Endocrinol Metab Clin N Am 39:381–400 . doi:10.1016/j.ecl.2010.02.016table of contents
Hollo A, Clemens Z, Kamondi A, Lakatos P, Szucs A (2012) Correction of vitamin D deficiency improves seizure control in epilepsy: a pilot study. Epilepsy Behav 24:131–133. doi:10.1016/j.yebeh.2012.03.011
Kalueff AV, Minasyan A, Keisala T, Kuuslahti M, Miettinen S, Tuohimaa P (2006) Increased severity of chemically induced seizures in mice with partially deleted vitamin D receptor gene. Neurosci Lett 394:69–73. doi:10.1016/j.neulet.2005.10.007
Kalueff AV, Minasyan A, Tuohimaa P (2005) Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice. Brain Res Bull 67:156–160. doi:10.1016/j.brainresbull.2005.06.022
Keeney JT, Butterfield DA (2015) Vitamin D deficiency and Alzheimer disease: common links. Neurobiol Dis 84:84–98. doi:10.1016/j.nbd.2015.06.020
Lips P (2006) Vitamin D physiology. Prog Biophys Mol Biol 92:4–8. doi:10.1016/j.pbiomolbio.2006.02.016
Morre DJ, Brightman AO (1991) NADH oxidase of plasma membranes. J Bioenerg Biomembr 23:469–489
Patel M, Li QY (2003) Age dependence of seizure-induced oxidative stress. Neuroscience 118:431–437
Paxinos GWC (1997) The rat brain in stereotaxic coordinates 3rd edn. Academic Press, New York
Pitkanen A, Lukasiuk K (2009) Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav 14(Suppl 1):16–25. doi:10.1016/j.yebeh.2008.09.023
Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281–294
Shellhaas RA, Joshi SM (2010) Vitamin D and bone health among children with epilepsy. Pediatr Neurol 42:385–393. doi:10.1016/j.pediatrneurol.2009.12.005
Siegel A, Malkowitz L, Moskovits MJ, Christakos S (1984) Administration of 1,25-dihydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats. Brain Res 298:125–129
Somera-Molina KC et al. (2007) Glial activation links early-life seizures and long-term neurologic dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulation. Epilepsia 48:1785–1800. doi:10.1111/j.1528-1167.2007.01135.x
de Souza AC, Yehia HC, Sato MA, Callan D (2013) Brain activity underlying auditory perceptual learning during short period training: simultaneous fMRI and EEG recording. BMC Neurosci 14:8. doi:10.1186/1471-2202-14-8
Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500
Tetich M et al. (2005) Effects of PRI-2191--a low-calcemic analog of 1,25-dihydroxyvitamin D3 on the seizure-induced changes in brain gene expression and immune system activity in the rat. Brain Res 1039:1–13. doi:10.1016/j.brainres.2005.01.034
Uyanikgil Y, Ozkeskek K, Cavusoglu T, Solmaz V, Tumer MK, Erbas O (2016) Positive effects of ceftriaxone on pentylenetetrazol-induced convulsion model in rats. Int J Neurosci 126:70–75. doi:10.3109/00207454.2014.991821
Vaidya A, Brown JM, Williams JS (2015) The renin-angiotensin-aldosterone system and calcium-regulatory hormones. J Hum Hypertens 29:515–521. doi:10.1038/jhh.2014.125
Vezzani A, Aronica E, Mazarati A, Pittman QJ (2013a) Epilepsy and brain inflammation. Exp Neurol 244:11–21. doi:10.1016/j.expneurol.2011.09.033
Vezzani A, Friedman A, Dingledine RJ (2013b) The role of inflammation in epileptogenesis. Neuropharmacology 69:16–24. doi:10.1016/j.neuropharm.2012.04.004
Wharton B, Bishop N (2003) Rickets. Lancet 362:1389–1400. doi:10.1016/S0140-6736(03)14636-3
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The experimental procedures employed in the present study were approved by the Animal Ethics Committee. All experiments were carried out according to the Guide for the Care and Use of Laboratory Animals, as confirmed by the National Institute of Health in the USA.
Conflict of interest
The authors declare that they have no conflict of interest.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
Rights and permissions
About this article
Cite this article
Uyanıkgil, Y., Solmaz, V., Çavuşoğlu, T. et al. Inhibitor effect of paricalcitol in rat model of pentylenetetrazol-induced seizures. Naunyn-Schmiedeberg's Arch Pharmacol 389, 1117–1122 (2016). https://doi.org/10.1007/s00210-016-1273-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-016-1273-z